Federal Court of Appeal clarifies law on patentability of methods of medical treatment
Drug pricing: PMPRB releases “What We Learned” Report on guidelines consultation
Federal Court finds trademark confusion between the names of two approved biologics
Federal Court of Appeal clarifies scope of implied licence on sale of patented medicine
Federal Court of Appeal Decides Case Splitting through NOAs is an Abuse of Process
Federal Court upholds PMPRB jurisdiction based on “clinical similarities”
Pharma in Brief’s 2023 Year in Review and Trends for 2024
Federal Court Notice on Use of Artificial Intelligence in Court Proceedings
New Canadian Drug Agency formed, while National Pharmacare bill is delayed into 2024
Subscribe: Subscribe via RSS
Firm/Org